Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of combining bicalutamide with sunitinib in patients with renal cell carcinoma resistant to tyr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)
• bicalutamide (bicalutamide)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: RECRUITING